View:
Download DOC
Download PDF
SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Hurvitz Eli
(Last) (First) (Middle)
C/O ORTHODONTIX, 2 SNUTIT ST
SCIENCE PARK, POB 455
(Street)
CARMIEL, ISRAEL 21000
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ORTHODONTIX INC [ ORTX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
12/31/2006
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/31/2006 A 2,886,447(1) A (1) 2,886,447 I By Partnership
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy) $0.001 12/31/2006 A 1,616,100 (2) 03/16/2010 Common Stock 1,616,100 (3) 1,616,100 I By Partnership
Stock Options (Right to Buy) $0.001 12/31/2006 A 1,768,402 (4) 03/16/2010 Common Stock 1,768,402 (5) 3,384,502 I By Partnership
Explanation of Responses:
1. Received in exchange for 47,256 ordinary shares of Protalix Ltd. (Protalix) in connection with the merger (the Merger) of Protalix into a wholly-owned subsidiary of Orthodontix, Inc. (Orthodontix). The shares acquired consist of 1,378,278 shares of Common Stock held by Pontifax (Cayman) L.P. and 1,508,169 of Common Stock held by Pontifax (Israel) L.P. Mr. Hurvitz disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein.
2. All shares of Common Stock underlying the options have vested prior to the date of the transaction.
3. Received in connection with the Merger in exchange for options to acquire 26,710 ordinary shares of Protalix. 771,688 of the shares of Common Stock underlying the options are held by Pontifax (Cayman) L.P., and 844,412 of the shares of Common Stock underlying the options are held by Pontifax (Israel) L.P. Mr. Hurvitz disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein.
4. 50% of the options vested on January 1, 2007, and an additional 10% of the options will vest at the end of each three-month period thereafter.
5. Received in connection with the Merger in exchange for options to acquire 28,700 ordinary shares of Protalix. 844,412 of the shares of Common Stock underlying the options are held by Pontifax (Cayman) L.P., and 923,990 of the shares of Common Stock underlying the options are held by Pontifax (Israel) L.P. Mr. Hurvitz disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein.
David Aviezer, Power of Attorney 01/04/2007
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
                                POWER OF ATTORNEY

                  KNOW ALL BY THESE PRESENTS, that the undersigned hereby
constitutes and appoints David Aviezer, Ph.D., MBA and Yossi Maimon the
undersigned's true and lawful attorney-in-fact to: (i) execute for and on behalf
of the undersigned, Forms 3, 4, and 5 in accordance with Section 16(a) of the
Securities Exchange Act of 1934, as amended and the rules thereunder in
connection with the undersigned's holdings of and transactions in securities
issued by Orthodontix, Inc., a Florida corporation (the "Company"); (ii) do and
perform any and all acts for and on behalf of the undersigned which may be
necessary or desirable to complete and execute any such Form 3, 4, or 5 and
timely file such form with the United States Securities and Exchange Commission
and any required stock exchange or similar authority, including the American
Stock Exchange and (iii) take any other action of any type whatsoever in
connection with the foregoing which, in the opinion of such attorney-in-fact,
may be of benefit to, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney
shall be in such form and shall contain such terms and conditions as such
attorney-in-fact may approve in such attorney-in-fact's discretion.

                  The undersigned hereby grants to such attorney-in-fact full
power and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorney-in-fact, in
serving in such capacity at the request of the undersigned, is not assuming, nor
is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934, as amended.

                  This Power of Attorney shall remain in full force and effect
until the undersigned is no longer required to file Forms 3, 4, and 5 with
respect to the undersigned's holdings of and transactions in securities issued
by the Company, unless earlier revoked by the undersigned in a signed writing
delivered to the foregoing attorney-in-fact.

                  IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of December 12, 2006.

                                             /s/ Eli Hurvitz
                                             -----------------------------------
                                             Name: Eli Hurvitz